Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications

Ramya Ranganathan1,*, Shruthilaya Madanmohan1,*, Akila Kesavan1, Ganga Baskar1, Yoganathan Ramia Krishnamoorthy2, Roy Santosham3, D Ponraju4, Suresh Kumar Rayala2, Ganesh Venkatraman1 1Department of Human Genetics, Sri Ramachandra University, Porur, 2Department of Biotechnology, Indian Institute of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ranganathan R, Madanmohan S, Kesavan A, Baskar G, Krishnamoorthy YR, Santosham R, Ponraju D, Rayala SK, Venkatraman G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/3ac24b5af128418f91450e4319f5aa78
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3ac24b5af128418f91450e4319f5aa78
record_format dspace
spelling oai:doaj.org-article:3ac24b5af128418f91450e4319f5aa782021-12-02T00:40:17ZNanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications1176-91141178-2013https://doaj.org/article/3ac24b5af128418f91450e4319f5aa782012-02-01T00:00:00Zhttp://www.dovepress.com/nanomedicine-towards-development-of-patient-friendly-drug-delivery-sys-a9332https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Ramya Ranganathan1,*, Shruthilaya Madanmohan1,*, Akila Kesavan1, Ganga Baskar1, Yoganathan Ramia Krishnamoorthy2, Roy Santosham3, D Ponraju4, Suresh Kumar Rayala2, Ganesh Venkatraman1 1Department of Human Genetics, Sri Ramachandra University, Porur, 2Department of Biotechnology, Indian Institute of Technology, Madras, 3Department of Radiology and Imaging Sciences, Sri Ramachandra University, Porur, Chennai, 4Safety Engineering Division, Nuclear and Engineering Safety Group, Indira Gandhi Center for Atomic Research, Kalpakkam, India*Authors contributed equally to this workAbstract: The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeting with enhanced tumor-killing. Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important area of nanomedicine. Currently several nanomaterial-based drug-delivery systems are in vogue and several others are in various stages of development. Tumor-targeted drug-delivery systems are envisioned as magic bullets for cancer therapy and several groups are working globally for development of robust systems.Keywords: patient-friendly, drug-delivery systems, cancer, nanomedicineRanganathan RMadanmohan SKesavan ABaskar GKrishnamoorthy YRSantosham RPonraju DRayala SKVenkatraman GDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 1043-1060 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Ranganathan R
Madanmohan S
Kesavan A
Baskar G
Krishnamoorthy YR
Santosham R
Ponraju D
Rayala SK
Venkatraman G
Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
description Ramya Ranganathan1,*, Shruthilaya Madanmohan1,*, Akila Kesavan1, Ganga Baskar1, Yoganathan Ramia Krishnamoorthy2, Roy Santosham3, D Ponraju4, Suresh Kumar Rayala2, Ganesh Venkatraman1 1Department of Human Genetics, Sri Ramachandra University, Porur, 2Department of Biotechnology, Indian Institute of Technology, Madras, 3Department of Radiology and Imaging Sciences, Sri Ramachandra University, Porur, Chennai, 4Safety Engineering Division, Nuclear and Engineering Safety Group, Indira Gandhi Center for Atomic Research, Kalpakkam, India*Authors contributed equally to this workAbstract: The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeting with enhanced tumor-killing. Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important area of nanomedicine. Currently several nanomaterial-based drug-delivery systems are in vogue and several others are in various stages of development. Tumor-targeted drug-delivery systems are envisioned as magic bullets for cancer therapy and several groups are working globally for development of robust systems.Keywords: patient-friendly, drug-delivery systems, cancer, nanomedicine
format article
author Ranganathan R
Madanmohan S
Kesavan A
Baskar G
Krishnamoorthy YR
Santosham R
Ponraju D
Rayala SK
Venkatraman G
author_facet Ranganathan R
Madanmohan S
Kesavan A
Baskar G
Krishnamoorthy YR
Santosham R
Ponraju D
Rayala SK
Venkatraman G
author_sort Ranganathan R
title Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_short Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_full Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_fullStr Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_full_unstemmed Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_sort nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/3ac24b5af128418f91450e4319f5aa78
work_keys_str_mv AT ranganathanr nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT madanmohans nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT kesavana nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT baskarg nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT krishnamoorthyyr nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT santoshamr nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT ponrajud nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT rayalask nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT venkatramang nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
_version_ 1718403547942354944